European equities traded in the US as American depositary receipts were lower late Thursday morning, declining 0.4% to 1,444.8 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and semiconductor company Sequans Communications (SQNS), which rose 2.9% and 2.5% respectively. They were followed by furniture maker Natuzzi (NTZ) and internet advertising firm Criteo (CRTO), which were up 1.5% and 1.4% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and health technology conglomerate Royal Philips (PHG), which fell 6.2% and 2.4% respectively. They were followed by oil and gas company Eni (E) and accommodations booking company trivago (TRVG), which were down 1.8% and 1.3% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Autolus Therapeutics (AUTL), which climbed 18.4% and 2% respectively. They were followed by telecommunications operator Vodafone Group (VOD) and biopharmaceutical company Verona Pharma (VRNA), which increased 1% and 0.8% respectively.

The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company NuCana (NCNA), which dropped 4.1% and 3.2% respectively. They were followed by alcoholic beverage company Diageo (DEO) and biotech firm Trinity Biotech (TRIB), which lost 2.7% and 2.5% respectively.